Search / Trial NCT06615388

Low Energy Availability and Cardiovascular Disease

Launched by LIVERPOOL HOPE UNIVERSITY · Sep 24, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

Low Energy Availability Cardiovascular Diseases Physically Active Females

ClinConnect Summary

This clinical trial is studying the effects of low energy availability (LEA) on cardiovascular health in elite female athletes. LEA occurs when the body doesn't get enough energy to perform essential functions, which can negatively impact both physical and mental health, especially for athletes. The researchers want to explore how LEA might be linked to heart issues, and they aim to learn more about the role of DNA changes (known as DNA methylation) in this relationship.

To participate in this trial, you must be a cisgender female between the ages of 18 and 35 who is an elite athlete, meaning you compete at a high level in your sport. The study is currently recruiting participants in the United Kingdom. If you join, you can expect to undergo various assessments to help researchers understand how low energy levels may affect your heart health. It's important to note that certain individuals, such as those who smoke, are pregnant, or have specific heart conditions, are not eligible to participate. This research could lead to valuable insights into how energy levels impact athletes' overall heart health.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Cisgender females
  • Aged 18 to 35 to avoid recruiting peri or postmenopausal females
  • Trained to elite female athletes based on McKay and colleagues\' (2021) criteria for participation classification framework. For example, trained (local-level representation), highly trained (competing at the national level) and elite (competing at the international level).
  • Females living in the United Kingdom.
  • Exclusion Criteria:
  • Biological Males
  • Females aged over 35
  • Sedentary females
  • Habitual smokers
  • Volunteers with any previous experience with Syncope
  • Volunteers with any previous diagnosis of ischaemic heart disease, myopathy or any neuromuscular disorder
  • Anticoagulants users
  • Pregnant women
  • Volunteers on lipid-lowering medication
  • Taking hormonal contraception (copper IUDs are acceptable)

About Liverpool Hope University

Liverpool Hope University is a prestigious higher education institution dedicated to fostering research and innovation across various disciplines, including health and clinical sciences. As a sponsor of clinical trials, the university emphasizes a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry. With a focus on ethical standards and collaboration with healthcare professionals, Liverpool Hope University aims to contribute to the development of effective therapies and interventions, positioning itself as a leader in the field of clinical research and education.

Locations

Liverpool, Merseyside, United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0